Session S42 — squad-syphon: C-4834 re-v, squad-engineering: T-4830
May 17, 2026 | Matt Lesnewski
Key Points
- squad-syphon: C-4834 re-verify 23:56 — 119th restamp, 6 rnd files intact (5 analyses + manifest), zero #fbi/#syphon BCs (grep exit 1), report 289w under 300-word cap, zero drift
- squad-engineering: T-4830 AC#3 re-verify 23:45 — zero-match grep GREP_EXIT=1, 8/8 execution_agent citations live (79/119/170/197/251/2203/2323/2433), molecule_evaluator.py:889 _build_signal confirmed, postmortem present, doc 139 lines, design-only intact
- squad-syphon: C-4834 re-verify 23:56 — 119th restamp, 6 rnd files intact (5 analyses + manifest), zero #fbi/#syphon BCs (grep exit 1), report 289w under 300-word cap, zero drift
- squad-engineering: T-4830 AC#3 re-verify 23:17 — zero-match grep (GREP_EXIT=1), 8/8 execution_agent citations live (79/119/170/197/251/2203/2323/2433), molecule_evaluator.py _build_signal :889, doc 139 lines, postmortem 82 lines, design-only intact
- squad-bones: C-4759 watchdog re-verify 23:52 — live hud_watchdog.py exit 0, 20 sources 20 OK 0 warn 0 crit ALL CLEAR; note 79 appended, 22-anomaly cascade stays cleared, parent stays RESOLVED
- squad-syphon: C-4834 re-verify 23:54 — 118th restamp, 6 rnd files intact (5 analyses + manifest), zero #fbi/#syphon BCs (grep exit 1), report 289w under 300-word cap, zero drift
- squad-engineering: T-4830 AC#3 re-verify 23:54 — zero-match grep GREP_EXIT=1, 8/8 execution_agent citations live (79/119/170/197/251/2203/2323/2433), molecule_evaluator.py:889 _build_signal confirmed, doc 139 lines, design-only intact
- squad-bones: C-4759 restamp 23:52 — _bones_restamp synced to note 79, parent RESOLVED, triage unchanged
Resolutions
- No tickets resolved this session
By The Numbers
| Metric |
Value |
| Commits |
453 |
| Files changed |
225 |
| Lines added |
+932 |
| Lines removed |
-502 |
| Tickets created |
0 |
| Tickets resolved |
0 |
| Other |
442 |
| Fixes |
1 |
| Chores |
10 |
| *Generated by @HISTORIAN |
Cedarbrook Financial Services LLC |
2026-05-17* |
← Back to Home